SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Link Pharma Chem informs about unaudited financial results

14 Aug 2023 Evaluate

Pursuant to Regulations 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Link Pharma Chem has informed that the Board has at its meeting held on today approved the Unaudited Financial Results of the Company for the quarter ended June 30, 2023. The company has enclosed Unaudited Financial Results along with Limited Review Report for the quarter ended on June 30, 2023. The meeting of the Board of Directors commenced at 11:30 am and concluded at 02:45 pm.

The above information is a part of company’s filings submitted to BSE.

Link Pharma Chem Share Price

28.47 -1.02 (-3.46%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3653.10
Tata Chemicals 704.05
SRF 2464.40
Pidilite Inds. 1390.15
Deepak Nitrite 1537.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×